1
Registered trials
1
Recruiting
1
Unique sponsors
3
Unique IMPs
0
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
V
Various (ATC V)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Checkpoint inhibitor (PD-1)
1 substance
Platinum compound
1 substance
Phase II:
1
Phase II
1 trial-
RecruitingIRCCS Istituto Nazionale Tumori Fondazione Pascale AcademicCALCIUM LEVOFOLINATE PENTAHYDRATE; NIVOLUMAB; OXALIPLATIN
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| IRCCS Istituto Nazionale Tumori Fondazione Pascale | Academic | 1 | Phase II | 1 |
New trials by year
2025
1